US Grants Zero-Tariff on Indian Specialty Drugs! 💊 | Nifty Dips 0.28% to 22,716 Amid Rising Treasury Yields..... 29-Sept-26

Defensive outperformance anchored Dalal Street today as Indian pharma stocks advanced following Washington's decision to grant zero-tariff status to specialty and rare-disease formulations imported from India and 19 other nations. However, benchmark gauges finished lower at 22,716 as sticky inflation pushed US Treasury yields higher and elevated crude kept input-cost concerns alive. Join tonight’s wrap-up as we map the support grid for 30-Sep-26.